Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

BMP signaling affects hair color by interacting with the MC-1R pathway.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Insulin resistance and nesfatin-1 are linked to acne severity.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

CRH promotes fat production in skin cells, affecting conditions like acne.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Estrogen therapy can reduce skin aging but has cancer risks.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Testosterone may slow down wound healing and increase inflammation.

Quercetin may help with PCOS symptoms, but more research is needed.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.